by The Francis Crick Institute Credit: Unsplash/CC0 Public Domain Patients receiving in-hospital dialysis treatment for kidney disease produce a larger neutralizing antibody response when given the Pfizer-BioNTech COVID-19 vaccine, compared to the Oxford-AstraZeneca vaccine, according to laboratory findings published today (Thursday) as a Correspondence in The Lancet. It is reported that immunocompromised patients will be prioritized to...
